Real-time enrollment status for this advanced non-small cell lung cancer clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 11:09 PM UTC
| NCT Number | NCT07222566 |
| Recruiting Status | Recruiting |
| Condition | Advanced Non-Small Cell Lung Cancer |
| Phase | PHASE3 |
| Target Enrollment | 1,410 participants |
| Active Locations | 206 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | August 17, 2026 (1 week ago) |
As of August 28, 2026: Clinical trial NCT07222566 is currently recruiting participants. This phase3 study for advanced non-small cell lung cancer is actively seeking new participants at 206 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07222566 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 206 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07222566 was last updated 1 week ago (August 17, 2026). HelloStudys verifies this status automatically.